Abstract
The need for gastrointestinal (GI) endoscopy for patients under antithrombotic therapy has recently been increasing. The Guidelines for antithrombotic therapy in GI endoscopy is different between Japan and Western countries. We investigated the clinical practice of the management of antithrombotic therapy and the frequency of bleeding and thrombo-embolism in GI endoscopy. About 80% of the endoscopists had performed an invasive procedure for the patients under antithrombotic therapy. In a half of them the problems were caused by operator error. After an invasive procedure, half of the endoscopists prescribed antiulcerative medication, and 20% of the endoscopists had performed endoscopic preventive hemostasis. No GI bleeding occurred in this investigation. However, 10 thrombo-embolic events occurred during cessation of the antithrombotic therapy. Antithrombotic therapy should be stopped with exact assessment and informed consent. Furthermore, evidence in Japanese patients established by the Japan Gastroenterological Endoscopy Society is required.
| Original language | English |
|---|---|
| Pages (from-to) | 1806-1811 |
| Number of pages | 6 |
| Journal | Gastroenterological Endoscopy |
| Volume | 54 |
| Issue number | 6 |
| Publication status | Published - 2012 Jun |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Gastroenterology
- Radiology Nuclear Medicine and imaging
Cite this
Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy. / Kikuchi, Daisuke; Furuhata, Tsukasa; Iizuka, Toshiro; Yamada, Akihiro; Yamashita, Satoshi; Fujimoto, Ai; Nakamura, Masanori; Matsui, Akira; Mitani, Toshifumi; Ogawa, Osamu; Hoteya, Shu; Kaise, Mitsuru.
In: Gastroenterological Endoscopy, Vol. 54, No. 6, 06.2012, p. 1806-1811.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Clinical practice of the management of antithrombotic therapy in gastrointestinal endoscopy
AU - Kikuchi, Daisuke
AU - Furuhata, Tsukasa
AU - Iizuka, Toshiro
AU - Yamada, Akihiro
AU - Yamashita, Satoshi
AU - Fujimoto, Ai
AU - Nakamura, Masanori
AU - Matsui, Akira
AU - Mitani, Toshifumi
AU - Ogawa, Osamu
AU - Hoteya, Shu
AU - Kaise, Mitsuru
PY - 2012/6
Y1 - 2012/6
N2 - The need for gastrointestinal (GI) endoscopy for patients under antithrombotic therapy has recently been increasing. The Guidelines for antithrombotic therapy in GI endoscopy is different between Japan and Western countries. We investigated the clinical practice of the management of antithrombotic therapy and the frequency of bleeding and thrombo-embolism in GI endoscopy. About 80% of the endoscopists had performed an invasive procedure for the patients under antithrombotic therapy. In a half of them the problems were caused by operator error. After an invasive procedure, half of the endoscopists prescribed antiulcerative medication, and 20% of the endoscopists had performed endoscopic preventive hemostasis. No GI bleeding occurred in this investigation. However, 10 thrombo-embolic events occurred during cessation of the antithrombotic therapy. Antithrombotic therapy should be stopped with exact assessment and informed consent. Furthermore, evidence in Japanese patients established by the Japan Gastroenterological Endoscopy Society is required.
AB - The need for gastrointestinal (GI) endoscopy for patients under antithrombotic therapy has recently been increasing. The Guidelines for antithrombotic therapy in GI endoscopy is different between Japan and Western countries. We investigated the clinical practice of the management of antithrombotic therapy and the frequency of bleeding and thrombo-embolism in GI endoscopy. About 80% of the endoscopists had performed an invasive procedure for the patients under antithrombotic therapy. In a half of them the problems were caused by operator error. After an invasive procedure, half of the endoscopists prescribed antiulcerative medication, and 20% of the endoscopists had performed endoscopic preventive hemostasis. No GI bleeding occurred in this investigation. However, 10 thrombo-embolic events occurred during cessation of the antithrombotic therapy. Antithrombotic therapy should be stopped with exact assessment and informed consent. Furthermore, evidence in Japanese patients established by the Japan Gastroenterological Endoscopy Society is required.
UR - http://www.scopus.com/inward/record.url?scp=84864267896&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864267896&partnerID=8YFLogxK
M3 - Article
VL - 54
SP - 1806
EP - 1811
JO - Gastroenterological Endoscopy
JF - Gastroenterological Endoscopy
SN - 0387-1207
IS - 6
ER -